216 related articles for article (PubMed ID: 36375457)
1. Imaging Spectrum in Chronic Pulmonary Aspergillosis.
Garg M; Bhatia H; Chandra T; Debi U; Sehgal IS; Prabhakar N; Sandhu MS; Agarwal R
Am J Trop Med Hyg; 2023 Jan; 108(1):15-21. PubMed ID: 36375457
[TBL] [Abstract][Full Text] [Related]
2. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.
Denning DW; Cadranel J; Beigelman-Aubry C; Ader F; Chakrabarti A; Blot S; Ullmann AJ; Dimopoulos G; Lange C;
Eur Respir J; 2016 Jan; 47(1):45-68. PubMed ID: 26699723
[TBL] [Abstract][Full Text] [Related]
3. Clinical Impact of Chronic Pulmonary Aspergillosis in Patients with Nontuberculous Mycobacterial Pulmonary Disease and Role of Computed Tomography in the Diagnosis.
Maruguchi N; Tanaka E; Okagaki N; Tanaka Y; Sakamoto H; Takeda A; Yamamoto R; Nakamura S; Matsumura K; Ueyama M; Ikegami N; Kaji Y; Hashimoto S; Hajiro T; Taguchi Y
Intern Med; 2023 Nov; 62(22):3291-3298. PubMed ID: 36927976
[TBL] [Abstract][Full Text] [Related]
4. Chronic pulmonary aspergillosis.
Schweer KE; Bangard C; Hekmat K; Cornely OA
Mycoses; 2014 May; 57(5):257-70. PubMed ID: 24299422
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and diagnosis of chronic pulmonary aspergillosis in Chinese patients.
Hou X; Zhang H; Kou L; Lv W; Lu J; Li J
Medicine (Baltimore); 2017 Oct; 96(42):e8315. PubMed ID: 29049239
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and outcome of patients with chronic pulmonary aspergillosis in China: A retrospective, observational study.
Niu Y; Li J; Shui W; Li D; Yu C; Fu X; Zhang C
J Mycol Med; 2020 Dec; 30(4):101041. PubMed ID: 32950379
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary diseases with imaging findings mimicking aspergilloma.
Gazzoni FF; Severo LC; Marchiori E; Guimarães MD; Garcia TS; Irion KL; Camargo JJ; Felicetti JC; de Mattos Oliveira F; Hochhegger B
Lung; 2014 Jun; 192(3):347-57. PubMed ID: 24615678
[TBL] [Abstract][Full Text] [Related]
8. Different forms of pulmonary aspergillosis: A pictorial essay.
Tamkeviciute L; Tumenas A; Zaveckiene J; Irion K; Franquet T; Radike M
Eur J Radiol; 2024 Feb; 171():111290. PubMed ID: 38219353
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of Pulmonary Aspergillosis in Hyper-IgE Syndrome with Autosomal-Dominant STAT3 Deficiency.
Duréault A; Tcherakian C; Poiree S; Catherinot E; Danion F; Jouvion G; Bougnoux ME; Mahlaoui N; Givel C; Castelle M; Picard C; Chansdesris MO; Lortholary O; Lanternier F;
J Allergy Clin Immunol Pract; 2019; 7(6):1986-1995.e3. PubMed ID: 30878710
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Laboratory Features and Performance of an
Zhu RS; Zhou LH; Cheng JH; Luo Y; Qiu WJ; Huang JT; Jiang YK; Zhao HZ; Wang X; Chen ZQ; Zhu LP
Microbiol Spectr; 2023 Jun; 11(3):e0026423. PubMed ID: 37125929
[TBL] [Abstract][Full Text] [Related]
11. Pulsed echinocandin therapy in azole intolerant or multiresistant chronic pulmonary aspergillosis: A retrospective review at a UK tertiary centre.
Osborne W; Fernandes M; Brooks S; Grist E; Sayer C; Hansell DM; Wilson R; Shah A; Loebinger MR
Clin Respir J; 2020 Jun; 14(6):571-577. PubMed ID: 32077238
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities.
Baluku JB; Nuwagira E; Bongomin F; Denning DW
Int J Tuberc Lung Dis; 2021 Jul; 25(7):537-546. PubMed ID: 34183098
[No Abstract] [Full Text] [Related]
13. The Serum Level of IL-1B Correlates with the Activity of Chronic Pulmonary Aspergillosis.
Zhan M; Xu B; Zhao L; Li B; Xu L; Sun Q; Zhang J; Zhang Z; Chu H
Can Respir J; 2018; 2018():8740491. PubMed ID: 30363691
[TBL] [Abstract][Full Text] [Related]
14. Incidence and prevalence of chronic pulmonary aspergillosis in patients with post-tuberculosis lung abnormality: Results from a community survey in North India.
Soundappan K; Sehgal IS; Prabhakar N; Rana S; Raju R; Dhooria S; Prasad KT; Muthu V; Rudramurthy SM; Chakrabarti A; Garg M; Agarwal R
Mycoses; 2024 Mar; 67(3):e13711. PubMed ID: 38414309
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.
Saito T; Fujiuchi S; Tao Y; Sasaki Y; Ogawa K; Suzuki K; Tada A; Kuba M; Kato T; Kawabata M; Kurashima A; Sakatani M;
Infection; 2012 Dec; 40(6):661-7. PubMed ID: 22956473
[TBL] [Abstract][Full Text] [Related]
16. Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.
Cadranel J; Philippe B; Hennequin C; Bergeron A; Bergot E; Bourdin A; Cottin V; Jeanfaivre T; Godet C; Pineau M; Germaud P
Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3231-9. PubMed ID: 22782438
[TBL] [Abstract][Full Text] [Related]
17. An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
Sehgal IS; Dhooria S; Muthu V; Prasad KT; Agarwal R
Expert Rev Respir Med; 2020 Jul; 14(7):715-727. PubMed ID: 32249630
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in chronic pulmonary aspergillosis.
Izumikawa K
Respir Investig; 2016 Mar; 54(2):85-91. PubMed ID: 26879477
[TBL] [Abstract][Full Text] [Related]
19. Chronic pulmonary aspergillosis as a sequel to lobectomy for lung cancer.
Tamura A; Suzuki J; Fukami T; Matsui H; Akagawa S; Ohta K; Hebisawa A; Takahashi F
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):650-6. PubMed ID: 26323287
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
